This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: ISTH News

ISTH Endorses Latest Guidance for Management of COVID-19 and Thrombotic Disease

Monday, April 20, 2020   (0 Comments)
Posted by: Luke Blount
Share |

The ISTH has endorsed the latest guidance published in the Journal of the American College of Cardiology: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. 

"This important and timely review clearly outlines the evidence showing how COVID-19 may predispose patients to venous and arterial thrombosis and provides guidance for patients with mild to severe COVID-19," said ISTH President Claire McLintock, M.D. "The ISTH emphatically endorses this guidance and encourages health providers to consider the diagnosis and prevention of thrombotic and thromboembolic disease in the management of COVID-19. We look forward to working collaboratively and internationally to address many knowledge gaps that remain in the diagnosis and treatment of COVID-19.”

View the article here.


Membership Management Software Powered by YourMembership  ::  Legal